Hosted on MSN5d
First Drug OK'd for Chronic Rhinosinusitis With Nasal Polyps in Adolescents
The FDA broadened dupilumab's (Dupixent) approval as an add-on maintenance treatment for chronic rhinosinusitis with nasal ...
Targeted Oncology5d
Neoadjuvant Therapy Could Improve Outcomes for Nasal and Paranasal Sinus Cancer
Neoadjuvant chemotherapy prior to surgery and postoperative radiation therapy could improve organ preservation in patients ...
GlobalData on MSN4d
SoundHealth launches nasal measuring AI app to combat allergies
SONUcast uses meteorological data and nostril diameter to better calculate the likelihood of an allergic attack at any time.
15-Year-Old Boy Suffers Nasal Fracture and Mild Head Trauma Over Unwanted Stare
"A 15-year-old boy suffered a nasal septum fracture and a mild head trauma due to an unwelcome look." This was reported in a ...
News Medical12d
Pre-surgery chemotherapy shows promise for preserving vital organs in nasal and sinus cancer
"These results support chemotherapy before surgery as an effective intervention to improve the preservation of vital organs, bone, and tissue in patients with nasal and paranasal sinus squamous ...
Medindia7d
Chemotherapy Before Surgery: Improving Organ Preservation in Nose and Sinus Cancer
Chemotherapy before surgery improves chances of preserving critical structures like the eye and skull in patients with ...
HealthDay on MSN4d
Neoadjuvant Chemo Boosts Structure Preservation Rates in Nasal, Sinus Cancer
Neoadjuvant platinum-based chemotherapy improves structure preservation (SP) for patients with T3, T4a, and selected T4b ...
Parents urged to book their child in for free nasal flu vaccine by NHS
TODDLERS will get flu vaccines from next week as the NHS prepares for a rough winter. More than a million parents will ...
Dupixent® (dupilumab) Approved in the U.S. as First and Only Treatment for Adolescents with Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)
Following Priority Review, Dupixent is now available to patients as young as 12 years with inadequately controlled CRSwNP Current treatment options leave many patients with uncontrolled disease and ...
TMCnet1h
Mölnlycke and Ondine join forces against HAIs
Mölnlycke Health Care partners with Ondine for Steriwave distribution collaboration in the key markets of the UK, Europe and the Middle East. Gothenburg, Sweden 23 September 2024. Mölnlycke® Health ...
Nuance Pharma Announces Expansion of Bentrio License and Distribution Agreement with Altamira Therapeutics in East and South East Asia
Nuance Pharma (the "Company") today announced that it has agreed with Altamira Medica Ltd., an associate company of Altamira Therapeutics Ltd. (Nasdaq:CYTO), to extend the territory covered by the ...
Yahoo Finance7h
Mölnlycke(R) and Ondine Join Forces Against HAIs
Steriwave, a non-antibiotic, light-activated nasal decolonization therapy ... enabling us to provide comprehensive ...